Literature DB >> 14561497

Sexual differences in onset of disease and response to exercise in a transgenic model of ALS.

J H Veldink1, P R Bär, E A J Joosten, M Otten, J H J Wokke, L H van den Berg.   

Abstract

Transgenic mice that overexpress the mutant human SOD1 gene (hSOD1) serve as an animal model for amyotrophic lateral sclerosis (ALS). Age and sex are recognized as risk factors for ALS, but physical activity remains controversial. Therefore, we investigated the effect of exercise on the phenotype of male and female hSOD1 mice. Onset of disease, progression of disease and survival were measured in low-copy and high-copy hSOD1 mice that were randomized to an exercise or sedentary group. We found that onset of disease was different for the two sexes: significantly earlier in male than in female hSOD1 mice. Exercise delayed the onset of disease in female but not in male hSOD1 mice. Also, exercise delayed the total survival time in female high-copy hSOD1 mice. Muscle morphometry and motor neuron counts were similar in all experimental groups at the end of training. Sedentary female hSOD1 mice showed more frequently irregular estrous cycles suggesting a higher estrogen exposure in exercising female mice. These results suggest a possible neuroprotective effect of female sex hormones and support the view that ALS patients should not avoid regular exercise.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14561497     DOI: 10.1016/s0960-8966(03)00104-4

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  70 in total

1.  Gonadectomy and dehydroepiandrosterone (DHEA) do not modulate disease progression in the G93A mutant SOD1 rat model of amyotrophic lateral sclerosis.

Authors:  Antonio Hayes-Punzo; Patrick Mulcrone; Michael Meyer; Jacalyn McHugh; Clive N Svendsen; Masatoshi Suzuki
Journal:  Amyotroph Lateral Scler       Date:  2012-03-13

Review 2.  Gender differences in neurological disease: role of estrogens and cytokines.

Authors:  Anna Członkowska; Agnieszka Ciesielska; Grazyna Gromadzka; Iwona Kurkowska-Jastrzebska
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

3.  Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis.

Authors:  Timothy M Miller; Soo H Kim; Koji Yamanaka; Mark Hester; Priya Umapathi; Hannah Arnson; Liza Rizo; Jerry R Mendell; Fred H Gage; Don W Cleveland; Brian K Kaspar
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-12       Impact factor: 11.205

4.  Long-term exercise-specific neuroprotection in spinal muscular atrophy-like mice.

Authors:  Farah Chali; Céline Desseille; Léo Houdebine; Evelyne Benoit; Thaïs Rouquet; Bruno Bariohay; Philippe Lopes; Julien Branchu; Bruno Della Gaspera; Claude Pariset; Christophe Chanoine; Frédéric Charbonnier; Olivier Biondi
Journal:  J Physiol       Date:  2016-02-27       Impact factor: 5.182

5.  Neuroprotective effects of estradiol on motoneurons in a model of rat spinal cord embryonic explants.

Authors:  Andrea Cardona-Rossinyol; Margalida Mir; Víctor Caraballo-Miralles; Jerònia Lladó; Gabriel Olmos
Journal:  Cell Mol Neurobiol       Date:  2013-01-16       Impact factor: 5.046

6.  Antinociceptive effect of intracerebroventricular administration of D-serine on formalin-induced pain.

Authors:  Miho Ito; Masanobu Yoshikawa; Kenji Ito; Mitsumasa Matsuda; Xing Lu Jin; Shigeru Takahashi; Hiroyuki Kobayashi; Toshiyasu Suzuki
Journal:  J Anesth       Date:  2013-09-19       Impact factor: 2.078

7.  Effects of Tongue Force Training on Bulbar Motor Function in the Female SOD1-G93A Rat Model of Amyotrophic Lateral Sclerosis.

Authors:  Delin Ma; Jeffrey M Shuler; Aishwarya Kumar; Quincy R Stanford; Sudheer Tungtur; Hiroshi Nishimune; John A Stanford
Journal:  Neurorehabil Neural Repair       Date:  2016-09-24       Impact factor: 3.919

8.  Moderate exercise delays the motor performance decline in a transgenic model of ALS.

Authors:  Isabel Carreras; Sinan Yuruker; Nurgul Aytan; Lokman Hossain; Ji-Kyung Choi; Bruce G Jenkins; Neil W Kowall; Alpaslan Dedeoglu
Journal:  Brain Res       Date:  2009-12-05       Impact factor: 3.252

9.  Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis.

Authors:  Yi Zhang; Anna Cook; Jinho Kim; Sergei V Baranov; Jiying Jiang; Karen Smith; Kerry Cormier; Erik Bennett; Robert P Browser; Arthur L Day; Diane L Carlisle; Robert J Ferrante; Xin Wang; Robert M Friedlander
Journal:  Neurobiol Dis       Date:  2013-03-26       Impact factor: 5.996

Review 10.  Physical activity and neuroprotection in amyotrophic lateral sclerosis.

Authors:  Mary E McCrate; Brian K Kaspar
Journal:  Neuromolecular Med       Date:  2008-02-20       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.